From: Immunisation timeliness in a cohort of urban Aboriginal and Torres Strait Islander children
Vaccine | Eligible childrena N (%) | Total not received N (%) | Total received N (%) | No delay N (%) | Early N (%) | Delayed N (%) | Median number of weeks delayed Mdn (IQR) |
---|---|---|---|---|---|---|---|
PCV 1 (2 months) | 126 (90.0) | 1 (0.8) | 125 (99.2) | 99 (79.2) | 1 (0.8) | 25 (20.0) | 9.1 (17.6-1.3) |
PCV 2 (4 months) | 120 (85.7) | 7 (5.8) | 113 (94.2) | 72 (63.7) | 0 (0.0) | 41 (36.3) | 7.4 (16.4-3.4) |
PCV 3 (6 months) | 105 (75.0) | 13 (12.4) | 92 (87.6) | 54 (58.7) | 1 (1.1) | 37 (40.2) | 10.4 (26.1-5.1) |
DTP, polio & HepB 1 (2 months) | 126 (90.0) | 1 (0.8) | 125 (99.2) | 98 (78.4) | 1 (0.8) | 26 (20.8) | 9.0 (18.0-1.3) |
DTP, polio & HepB 2 (4 months) | 120 (85.7) | 7 (5.8) | 113 (94.2) | 72 (63.7) | 0 (0.0) | 41 (36.3) | 7.4 (16.4-3.4) |
DTP, polio & HepB 3 (6 months) | 105 (75.0) | 14 (13.3) | 91 (86.7) | 54 (59.3) | 1 (1.1) | 36 (39.6) | 10.5 (24.9-3.9) |
Hib 1 (2 months) | 126 (90.0) | 1 (0.8) | 125 (99.2) | 98 (78.4) | 1 (0.8) | 26 (20.8) | 9.0 (18.0-1.3) |
Hib 2 (4 months) | 120 (85.7) | 7 (5.8) | 113 (94.2) | 72 (63.7) | 0 (0.0) | 41 (36.3) | 7.4 (16.4-3.4) |
Hib 3 (6 months) | 105 (75.0) | 14 (13.3) | 91 (86.7) | 54 (59.3) | 1 (1.1) | 36 (39.6) | 10.5 (24.9-3.9) |
Rota 1 (2 months) | 126 (90.0) | 19 (15.1) | 107 (84.9) | 96 (89.7) | 1 (0.9) | 10 (9.3) | 1.4 (12.7-1.0) |
Rota 2 (4 months) | 120 (85.7) | 32 (26.7) | 88 (73.3) | 70 (79.5) | 0 (0.0) | 18 (20.5) | 2.9 (5.9-1.0) |
Rota 3 (6 months) | 105 (75.0) | 45 (42.9) | 60 (57.1) | 49 (81.7) | 1 (1.7) | 10 (16.7) | 1.4 (2.3-0.7) |
MMR (12 months) | 85 (60.7) | 3 (3.5) | 82 (96.5) | 38 (46.3) | 0 (0.0) | 44 (53.7) | 7.4 (15.9-3.4) |
MenC (12 months) | 85 (60.7) | 4 (4.7) | 81 (95.3) | 38 (44.7) | 0 (0.0) | 43 (50.6) | 7.3 (15.0-3.4) |
Hib 4 (12 months) | 85 (60.7) | 13 (15.3) | 72 (84.7) | 36 (50.0) | 0 (0.0) | 36 (50.0) | 5.8 (10.7-3.1) |
Varicella (18 months) | 65 (46.4) | 6 (9.2) | 59 (90.8) | 28 (47.5) | 3 (5.1) | 28 (47.5) | 12.8 (42.3-2.9) |
HepA (18 months) | 65 (46.4) | 15 (23.1) | 50 (76.9) | 13 (26.0) | 1 (2.0) | 36 (72.0) | 19.2 (37.7-4.1) |